Building on the inferencing acceleration introduced at Lenovo Tech World, this next phase of Hybrid AI execution expands the ...
Built for the Inference Era: As part of the Keysight Artificial Intelligence (KAI) portfolio, KAI Inference Builder emulates AI inference workloads at scale and validates full-stack deployments under ...
Morning Overview on MSN
Report: Nvidia is developing a $20B AI chip aimed at faster inference
Nvidia is reportedly developing a specialized processor aimed at accelerating AI inference, a move that could reshape how ...
ScaleFlux, FarmGPU, and Lightbits Labs today announced the public debut of a collaborative architecture designed to solve one of AI inference's most persistent challenges: the memory and I/O ...
Lightbits Labs Ltd. today is introducing a new architecture aimed at addressing one of the most stubborn bottlenecks in large-scale artificial intelligence inference: the growing mismatch between the ...
0G’s Sealed Inference takes a fundamentally different approach: privacy by code. The architecture makes unauthorized data ...
Nvidia's upcoming GTC conference will reveal CEO Jensen Huang's AI hardware, software, and partnership plans. Investors ...
Researchers present NorthPole – a brain-inspired chip architecture that blends computation with memory to process data efficiently at low-energy costs. Since its inception, computing has been ...
SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results